Claudius Rudin

1.2k total citations
16 papers, 845 citations indexed

About

Claudius Rudin is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Claudius Rudin has authored 16 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Claudius Rudin's work include Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Bone health and treatments (3 papers). Claudius Rudin is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Bone health and treatments (3 papers). Claudius Rudin collaborates with scholars based in United Kingdom, Finland and Switzerland. Claudius Rudin's co-authors include Walter M. Gregory, Mark T. Drayson, Jenny Byrne, Faith E. Davies, Roger G. Owen, Huw Roddie, Graham Jackson, Sue Bell, Sylvia Feyler and J. Anthony Child and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Claudius Rudin

15 papers receiving 826 citations

Peers

Countries citing papers authored by Claudius Rudin

Since Specialization

Citations

This map shows the geographic impact of Claudius Rudin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudius Rudin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudius Rudin more than expected).

Fields of papers citing papers by Claudius Rudin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudius Rudin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudius Rudin. The network helps show where Claudius Rudin may publish in the future.

Co-authorship network of co-authors of Claudius Rudin

This figure shows the co-authorship network connecting the top 25 collaborators of Claudius Rudin. A scholar is included among the top collaborators of Claudius Rudin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudius Rudin. Claudius Rudin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal 2018 ·PharmacoEconomics ·Abdullah Pandor, Matt Stevenson, John Stevens, Marrissa Martyn‐St James, Jean Hamilton, Jenny Byrne, Claudius Rudin, Andrew Rawdin, Ruth Wong	3
2	Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal 2016 ·PharmacoEconomics ·Irina A. Tikhonova, Martin Hoyle, Tristan Snowsill, Chris Cooper, (unknown), Claudius Rudin, Rubén Mújica-Mota	6
3	Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT 2013 ·Blood ·Esa Jantunen, Ariane Boumendil, Hervé Finel, (unknown), Peter Johnson, Alessandro Rambaldi, Andrew Haynes, Michel A. Duchosal, Wolfgang Bethge, Pierre Biron, Kristina Carlson, Charles Craddock, Claudius Rudin, Jürgen Finke, Gilles Salles, Frank Kroschinsky, Anna Sureda, Peter Dreger	52
4	Efficacy and side-effect profile of long-term bisphosphonate therapy in patients (pts) with multiple myeloma (MM): MRC myeloma IX study results. 2012 ·Journal of Clinical Oncology ·Gareth J. Morgan, Graham Jackson, Faith E. Davies, Ping Wu, Walter M. Gregory, Sue Bell, Alexander J. Szubert, Nuria Navarro Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, John Ashcroft, Fiona Ross, Jennifer A. Byrne, Huw Roddie, Claudius Rudin, Kevin Boyd, Gordon Cook, J. Anthony Child	1
5	Autologous Stem Cell Transplantation (ASCT) for Enteropathy-Associated T-Cell Lymphoma (EATL): Final Analysis of a Retrospective Study On the Behalf of Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT). 2012 ·Blood ·Esa Jantunen, Ariane Boumendil, Hervé Finel, (unknown), Peter Johnson, Alessandro Rambaldi, Andrew Haynes, Michel A. Duchosal, Lothar Kanz, Pierre Biron, (unknown), Charles Craddock, Claudius Rudin, Jürgen Finke, Gilles Salles, Peter Dreger, Anna Sureda	1
6	Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial 2011 ·The Lancet Oncology ·Gareth J. Morgan, J. Anthony Child, Walter M. Gregory, Alex J. Szubert, Kim Cocks, Sue Bell, Nuria Navarro-Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, A. John Ashcroft, Fiona M. Ross, Jenny Byrne, Huw Roddie, Claudius Rudin, Gordon Cook, Graham Jackson, Ping Wu, Faith E. Davies	117
7	Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation 2011 ·Blood ·Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Nigel H. Russell, Sue Bell, Alexander J. Szubert, Nuria Navarro Coy, Gordon Cook, Sylvia Feyler, Jenny Byrne, Huw Roddie, Claudius Rudin, Mark T. Drayson, Roger G. Owen, Fiona M. Ross, Graham Jackson, J. Anthony Child, (unknown)	141
8	First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial 2010 ·The Lancet ·Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Kim Cocks, Sue Bell, Alex J. Szubert, Nuria Navarro-Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, A. John Ashcroft, Fiona Ross, Jenny Byrne, Huw Roddie, Claudius Rudin, Gordon Cook, Graham Jackson, J. Anthony Child	407
9	Evaluation of 13q14 Status in Multiple Myeloma by Digital Single Nucleotide Polymorphism Technology 2009 ·Journal of Molecular Diagnostics ·(unknown), Lorna W. Harries, Sian Ellard, Claudius Rudin	0
10	Investigating the Targets of MIR-15a and MIR-16-1 in Patients with Chronic Lymphocytic Leukemia (CLL) 2009 ·PLoS ONE ·(unknown), Claudius Rudin, Lorna W. Harries	56
11	Evaluation of 13q14 Status in Patients with Chronic Lymphocytic Leukemia Using Single Nucleotide Polymorphism-Based Techniques 2009 ·Journal of Molecular Diagnostics ·(unknown), Sian Ellard, Claudius Rudin, (unknown), Teresa Davies, Lorna W. Harries	4
12	Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy 2007 ·Hematology ·Bhawna Sirohi, R Powles, (unknown), Heather Oakervee, (unknown), (unknown), Samar Kulkarni, Claudius Rudin, C Horton, Jennifer Treleaven, Gareth J. Morgan	2
13	Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft 2005 ·Hematology ·Bhawna Sirohi, R Powles, Claudius Rudin, Seema Singhal, Samar Kulkarni, Radovan Sašo, C Horton, Jayesh Mehta, Jennifer Treleaven	3
14	Cytochrome c Induces Caspase-Dependent Apoptosis in Intact Hematopoietic Cells and Overrides Apoptosis Suppression Mediated by bcl-2, Growth Factor Signaling, MAP-Kinase-Kinase, and Malignant Change 1998 ·Blood ·John M. Garland, Claudius Rudin	47
15	Cytochrome c Induces Caspase-Dependent Apoptosis in Intact Hematopoietic Cells and Overrides Apoptosis Suppression Mediated by bcl-2, Growth Factor Signaling, MAP-Kinase-Kinase, and Malignant Change 1998 ·Blood ·John M. Garland, Claudius Rudin	3
16	Concordant expression of class II and class III CD34 epitopes on haemopoietic cells in leukapheresis and cord blood samples with CD45/CD34 dual staining 1997 ·British Journal of Haematology ·Claudius Rudin, John M. Garland, M V Joyner	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact